Track funded deeptech companies, founders and investors across the UK startup ecosystem.
| Date | Startup | Funding | Round | Sector | Location | Connect | Website | Investor1 | Investor2 | Investor3 | Investor4 | Investor5 | Founder(s) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
29 Sept 2026 | 52North Neutrocheck is a rapid finger prick blood test that uses a biomarker detect... | £3,200,000 | |||||||||||
24 Sept 2026 | Basecamp Research Basecamp Research offers a drug discovery platform that combines genetic da... | £105,630,000 US$140,000,000 | |||||||||||
23 Sept 2026 | CSignum CSignum's EM2 is a hardware product family that uses electromagnetic signal... | £2,600,000 | |||||||||||
18 Sept 2026 | Big Picture Bio Big Picture Bio provides a platform that uses AI to model disease and propo... | £1,500,000 | |||||||||||
17 Sept 2026 | Chemify Chemify provides an automated chemistry discovery platform combining labora... | £22,000,000 | |||||||||||
17 Sept 2026 | MicroLub A protein-based ingredient that replaces fat's lubricating role with water ... | £7,500,000 | Leeds | ||||||||||
17 Sept 2026 | Eterna Regeneratives A keratin scaffold that forms a thin layer on tooth and bone surfaces. It i... | ||||||||||||
16 Sept 2026 | Axo Longevity Axo Longevity is a membership service that provides regular blood panels, a... | £3,710,000 US$5,000,000 | |||||||||||
15 Sept 2026 | Athernal Bio Athernal Bio develops targeted immunotherapies that recognise and remove hi... | £700,000 | |||||||||||
15 Sept 2026 | Magnitude Biosciences VivoScan is a platform that tests chemical compounds in living C. elegans u... | £1,300,000 | Durham | ||||||||||
15 Sept 2026 | Fuse Diagnostics Flip is an instrument-free molecular diagnostics platform combining proprie... | £1,000,000 | |||||||||||
14 Sept 2026 | Bitrobius Genetics Gentrafix is a plasmid-based platform that replicates in human cells and sp... | £700,000 | Cheshire | ||||||||||
9 Sept 2026 | ViaNautis polyNaut® is a non-viral delivery platform that uses targeted polymer nanov... | €20,000,000 | |||||||||||
9 Sept 2026 | Anemo Labs Anemo Labs makes a sensor device that samples urine and analyses scent usin... | £700,000 | |||||||||||
1 Sept 2026 | Pure Capture Innovations A carbon-based adsorbent and on-site testing service for water treatment th... | £530,000 | |||||||||||
19 Aug 2026 | Singular Photonics Singular Photonics produces image sensors that combine SPAD detectors with ... | £1,600,000 | |||||||||||
10 Aug 2026 | Mironid Mironid develops oral small-molecule LoAc compounds that target cAMP signal... | £34,110,000 US$46,000,000 | |||||||||||
29 Jul 2026 | Qureight Qureight offers an AI imaging platform that combines imaging services with ... | £15,000,000 | |||||||||||
23 Jul 2026 | Moa Technology Moa Technology offers a discovery platform and product pipeline for herbici... | £22,200,000 | |||||||||||
16 Jul 2026 | Silicon Microgravity Silicon Microgravity makes compact MEMS sensors for resilient motion and or... | £6,000,000 | |||||||||||
14 Jul 2026 | Draig Therapeutics DT-101 is an AMPA receptor potentiator and positive allosteric modulator. I... | £48,640,000 US$65,000,000 | Cardiff | ||||||||||
10 Jul 2026 | Alchemab Therapeutics Resiliome is a platform that combines deep sequencing of antibodies with a ... | £25,000,000 | |||||||||||
8 Jul 2026 | Healome Therapeutics Healome Therapeutics makes an eye-drop matrix that is liquid on application... | £2,000,000 | |||||||||||
6 Jul 2026 | OryxAlign OryxAlign is a hardware-focused services firm that designs, builds and mana... | £254,000,000 | |||||||||||
6 Jul 2026 | Revolver Therapeutics Revolver Therapeutics provides a discovery platform and peptide therapeutic... | £572 | Bath | ||||||||||
30 Jun 2026 | Neuronostics BioEP is an EEG-based biomarker platform that analyses routine EEG recordin... | £3,000,000 | |||||||||||
24 Jun 2026 | RQ Bio RQB01 is a long-acting monoclonal antibody candidate developed to provide s... | £87,090,000 US$115,000,000 | |||||||||||
23 Jun 2026 | Astral Systems Astral Systems supplies modular Multi-State Fusion reactors designed as com... | £23,000,000 | |||||||||||
23 Jun 2026 | TRIMTECH Therapeutics TRIMTECH Therapeutics develops proprietary small-molecule degrader platform... | £11,000,000 | |||||||||||
23 Jun 2026 | LabCycle LabCycle's AutoDecon is a system that cleans and processes single-use labor... | £180,000 |

1 Explore 319 UK deeptech startups and their founders, who have collectively raised £8.10B.
2 Easily sort, filter, and compare the UK's top startups — customise the list to your needs.
3 Discover top startups for investment, B2B sales, partnerships, hiring, and industry connections.
You can connect with fast-growing deeptech startups with the full list of recently funded startups from the UK.
Deeptech startups are built on scientific and engineering breakthroughs rather than lightweight software alone. Across the UK, founders are turning advances in AI, robotics, quantum, semiconductors, materials and climate science into commercially scalable companies.
The UK has one of Europe's strongest deeptech ecosystems, supported by world-class universities, specialist research labs and a maturing investor base. London, Cambridge, Oxford, Bristol, Manchester and Edinburgh continue to produce high-growth deeptech companies across pre-seed to growth stages.
Deeptech in this context includes startups where defensible IP, advanced R&D and technical complexity drive long-term value creation. These companies often take longer to scale than traditional software startups, but can create category-defining outcomes with stronger barriers to entry.
Use this page to explore the fastest growing deeptech startups in the UK, then review company profiles for websites, investors, locations and recent funding rounds.
That is our view of the most active deeptech startups in the UK. If you are building in this category, finding investors who understand technical risk, longer R&D cycles and IP-led business models is critical.
Deeptech refers to technology companies built on significant scientific or engineering innovation. Unlike many software-first businesses, deeptech startups usually rely on proprietary research, complex product development and technical teams with domain expertise.
Key deeptech categories in the UK include:
Foundational technologies for model training, inference optimisation, AI hardware and enterprise deployment.
Intelligent machines and autonomous systems for logistics, manufacturing, defence, agriculture and healthcare.
Quantum hardware, software and enabling components for next-generation computing performance.
Breakthrough technologies in energy, carbon management, manufacturing efficiency and resource optimisation.
Novel materials, semiconductors and engineering platforms that unlock better performance across industries.
The UK's research depth and venture ecosystem make it a strong launchpad for deeptech founders building globally competitive companies.
Deeptech startups build companies around scientific, engineering or technical breakthroughs rather than simple software applications. UK deeptech startups often work across AI, robotics, quantum, biotech, semiconductors, advanced materials, space, climate technology and hardware.
The UK is strong in deeptech because of its universities, research institutions, technical talent, spinout activity and specialist investor base. Cambridge, Oxford, London, Bristol, Edinburgh, Manchester and Sheffield are important hubs for science-led and engineering-led startup creation.
Deeptech startups raise funding from angel investors, specialist venture capital firms, university spinout funds, grant programmes and strategic industry partners. They often need more patient capital than software startups because product development, validation and commercialisation can take longer.
Investors in deeptech startups look for defensible intellectual property, strong technical founders, evidence that the technology works and a large commercial market. They also assess whether the company can move from research to repeatable customers without becoming trapped in the lab.
Deeptech startups often take longer to commercialise because they must prove complex technology, build prototypes, protect intellectual property, navigate regulation or integrate with industrial customers. The upside can be significant, but execution risk is usually higher than in standard software startups.